< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Notice from the European Patent Office dated 22 February 2021 concerning the amendment of Rules 19 and 143 EPC

März 2021

From 1 April 2021, inventors will no longer be notified by the EPO about being named in a patent application. In addition, applicants will no longer be required to indicate the full address of the inventor in the application, only the country and place of residence.

Amended Rule 19 (comes into force 1 April 2021):
  • Inventors are no longer notified by the EPO about their designation.
  • Applicants are no longer required to indicate the full address of the inventor only the country, city and post code.
  • Online filing tools will be updated so that they no longer have a dedicated field for entering a full address; nor will there be a dedicated field for “Company” or “Department” for inventors.
Amended Rule 143 (comes into force 1 Nov 2021):
  • Full addresses of inventors are no longer published in the EP patent register – only the country and place of residence.

Rule 20(1) still holds and is unaffected by either amended Rule 19 or Rule 143. An inventor can therefore still waive their right to be mentioned.

Reasons for the Changes:

Read the article here.

The EPO sends letters to notify inventors that they have been named on an application which is a considerable administrative burden (530,194 letters were sent in 2019 costing 307,000 EUR). In addition many of these letters are undeliverable due to incorrect addresses (36,000 in total). Updating online filing tools on the EPO IT systems will cost 50,000 EUR initially but save money in the long run.

Furthermore, due to data protection the EPO feel it is unnecessary to have the whole of the inventor’s address published on the EP patent register and that the name and city of the inventor is sufficient.

If you would like further advice on this or any other matter, please contact your usual HGF attorney or visit our Contact Page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Weiterlesen

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Weiterlesen
Event - 14. Januar 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Veranstaltungsdetails

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Weiterlesen

Colour in fashion and the difficulties of protecting it

Episode 2 Colour in fashion and the difficulties of protecting it  

Weiterlesen

Trade marks which are fashion products, and fashion products which are trade marks

Episode 3 Trade marks which are fashion products, and fashion products which are trade marks

Weiterlesen

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Weiterlesen

Trade mark rights protecting fashion designs

Episode 5 Trade mark rights protecting fashion designs

Weiterlesen